Hepşen S, Saat H, Akhanli P, Cakal E
Department of Endocrinology and Metabolism, University of Health Sciences, Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey.
Department of Medical Genetic, University of Health Sciences, Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey.
Acta Endocrinol (Buchar). 2022 Oct-Dec;18(4):512-515. doi: 10.4183/aeb.2022.512.
Subacute thyroiditis (SAT) is an inflammatory disease of the thyroid gland and commonly affects females. Despite adequate treatment, the recurrence of SAT can be seen in some patients. Although there is insufficient data about the reasons for recurrences, HLA predisposition is one of the reasons thought to be responsible and is a current issue for clinicians.
This case report presented the management of 7 SAT attacks of a patient who had HLA-B35:01 and B41:02 alleles in the genotype analysis.
A 37-year-old male patient who had consecutive 7 SAT attacks was presented in this report. Corticosteroid or non-steroidal anti-inflammatory drugs were initiated at each recurrence depending on the severity of clinical symptoms and laboratory findings. The genotype analysis showed the positivity for HLA-B35:01 and B41:02 alleles. The anti-thyroglobulin antibody was detected positive after the last attack. The patient was followed up as asymptomatic and euthyroid in the third month after the last attack.
The management of some SAT cases may be challenging for clinicians. Although recurrence can be seen despite adequate treatment, repetitive seven attacks are extraordinary in SAT. HLA genotyping showed co-occurrence of HLA-B35:01 and B41:02 alleles in our patient. The co-occurrence of these alleles has been described firstly in this case. Explaining high recurrence rates of SAT with these HLA alleles is difficult, though the present case may shed light on further studies.
亚急性甲状腺炎(SAT)是一种甲状腺的炎症性疾病,常见于女性。尽管进行了充分治疗,但部分患者仍会出现SAT复发。虽然关于复发原因的数据不足,但HLA易感性被认为是原因之一,也是临床医生当前关注的问题。
本病例报告介绍了一名基因型分析显示具有HLA - B35:01和B41:02等位基因的患者7次SAT发作的治疗情况。
本报告介绍了一名连续发作7次SAT的37岁男性患者。每次复发时,根据临床症状和实验室检查结果的严重程度,开始使用皮质类固醇或非甾体抗炎药。基因型分析显示HLA - B35:01和B41:02等位基因呈阳性。最后一次发作后检测到抗甲状腺球蛋白抗体呈阳性。在最后一次发作后的第三个月,对患者进行随访,结果显示其无症状且甲状腺功能正常。
对于临床医生而言,一些SAT病例的治疗可能具有挑战性。尽管进行了充分治疗仍可能出现复发,但SAT患者反复7次发作实属罕见。HLA基因分型显示我们的患者同时存在HLA - B35:01和B41:02等位基因。本病例首次描述了这些等位基因的同时出现。尽管本病例可能为进一步研究提供线索,但用这些HLA等位基因来解释SAT的高复发率仍很困难。